drugset / Trial / NCT02600520

Comparison of Rosuvastatin With Atorvastatin in Chronic Periodontitis

NCT02600520

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The present study is designed as a single-centre, randomized, controlled clinical trial to evaluate and compare the clinical and radiographic efficacy of two local drug delivery systems containing 1.2% RSV gel and 1.2% ATV gel in treatment of intrabony defects in patients with chronic periodontitis as an adjunct to SRP.

Timeline

Start
2014-11
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 1.2 % Other
Comparator Rosuvastatin Small molecule 1.2 % Other

Indications